ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 89 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 469 | 0.0% | 0.00% | – |
Q2 2023 | $0 | -100.0% | 469 | 0.0% | 0.00% | – |
Q1 2023 | $1 | 0.0% | 469 | 0.0% | 0.00% | – |
Q4 2022 | $1 | -99.9% | 469 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | -96.9% | 469 | -97.5% | 0.00% | – |
Q2 2022 | $32,000 | -56.2% | 18,878 | -46.8% | 0.00% | – |
Q1 2022 | $73,000 | -20.7% | 35,516 | +44.9% | 0.00% | -100.0% |
Q4 2021 | $92,000 | +15.0% | 24,515 | +59.4% | 0.00% | 0.0% |
Q3 2021 | $80,000 | +7900.0% | 15,382 | +5908.6% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 256 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 256 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | – | 256 | -20.7% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 323 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 323 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | -50.0% | 323 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | -50.0% | 323 | 0.0% | 0.00% | – |
Q3 2018 | $4,000 | 0.0% | 323 | 0.0% | 0.00% | – |
Q2 2018 | $4,000 | 0.0% | 323 | 0.0% | 0.00% | – |
Q1 2018 | $4,000 | – | 323 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |